fda warns semaglutide Novo Nordisk of Unreported Side Effects Tied to GLP-1 Patients FDA warns against compounded GLP-1

These innovations include smartwatch-based sensors, portable ECG devices, and patch-based monitors, each contributing to improved patient care and outcomes

A weekly injection requires one scheduled treatment day

What Makes Josie Stand Out Menopause-aware care from day one Personalized GLP-1 meds (compounded oral + injectables) Clear communication + fast shipping High-quality education, not just meds Refill flexibility (no auto-bill pressure) Easy-to-use portal with real-time tracking Kind, professional providers Resources that go beyond medication They truly want you to succeed not just get a package

Your satisfaction is our utmost priority

A health solution that is structurally available only to affluent urban populations is not a population health solution it is a premium product